Patient safety who collaborative high 5s topics
This presentation is the property of its rightful owner.
Sponsored Links
1 / 11

Patient Safety WHO collaborative High 5s topics PowerPoint PPT Presentation


  • 76 Views
  • Uploaded on
  • Presentation posted in: General

Patient Safety WHO collaborative High 5s topics . Prevention of patient care hand-over errors Prevention of wrong site/wrong procedure/wrong person surgical errors Accurate medicines reconciliation Prevention of high concentration drug errors Promotion of effective hand hygiene practices .

Download Presentation

Patient Safety WHO collaborative High 5s topics

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Patient safety who collaborative high 5s topics

Patient SafetyWHO collaborative High 5s topics

  • Prevention of patient care hand-over errors

  • Prevention of wrong site/wrong procedure/wrong person surgical errors

  • Accurate medicines reconciliation

  • Prevention of high concentration drug errors

  • Promotion of effective hand hygiene practices

http://www.who.int/patientsafety/solutions/high5s/en/index.html


Patient safety who collaborative high 5s topics

SOP - Management of

Concentrated Injectables

“worldwide evidence that concentrated injectable medicines have been involved in medication incidents resulting in death or serious harm”

WHO 2007

http://www.who.int/patientsafety/solutions/high5s/Managing-concentrated-injectables.pdf


Basic principles

Basic principles

  • Simplify and rationalise protocols and range of products

  • Minimise calculations and preparation in clinical setting

  • Procure ready-to-administer or ready-to use products that require no further dilution before use


Identified conc injectables

Identified Conc Injectables

  • Potassium Chloride and Phosphate soln

  • Heparin > 1000units/ml

  • Concentrated morphine & opiate injections

  • Hypertonic Saline

  • Magnesium Sulphate >50%

  • Any other injections in high concentrations that cannot be administered safely to patients.

  • Injectables as highlighted by reported incidents, e.g. ciclosporin, tranexamic acid, amiodarone.


Patient safety who collaborative high 5s topics

Process Flow used for

Managing Concentrated

Injectable Medicines


What is the problem kcl in conc ampoule form can be fatal if not handled properly

What is the problem?KCl in Conc ampoule form can be fatal if not handled properly!

Usage of KCl ampoules = ??? p.a.

Essential areas (ICU CCU ED) = ??p.a.

X reported incidents at XDHB in last 6 months and 1 nationally, all potentially serious.

Action taken already:

KCl concentrate ampoules stored securely on X wards in XX

DHBNZ Audit 2009

X x KCl premixes in use = XX p.a

Protocols rationalised to X documents (ICU & Adult)


How do we solve it

How do we solve it?

Add 3 more pre-mix bags over next 12 months and remove ampoules from all but essential clinical areas.

1. 10mmol KCl in 10% Glucose 500ml (GIK):

  • Currently bag made on ward by nursing staff

  • Estimate XDHB use @ 5000 bags p.a.

  • Premix would replace 5000 KCl ampoules and glucose bags

  • Release 1000hrs nurse’s time to care

  • Purchase premix for 1month trial in ward ?

  • Ready to start asap.


Patient safety who collaborative high 5s topics

2. 40mmol KCl in N/Saline 1000mL:

  • Currently bag made on ward by nursing staff

  • Estimate use @ 1500 bags p.a.

  • Purchase premix at $7.5k saving

  • Release 200hrs nurse’s time to care

  • Replace 6000 KCl ampoules

  • Introduce with education

    3. Paediatric bag 500ml:

  • Formula in consultation with consultants and Starship not yet finalised. (awaiting Aust stds)


Have we made a difference

Have we made a difference?

By adding 2 more premix bags, 1 x GIK, 1x N/S with KCl 40mmol to stock a total of 4 premixes.

XDHB would expect:

  • ↓ KCL amps by X p.a.

  • Conc KCl removed from wards

  • If KCL or K Phosphate to remain as clinically valid then that could be managed as controlled drug with two witnesses

  • Store KCl amps in essential areas only

  • Monitor errors reported

  • Minimise volumes of premix stored by improved stock rotation.


Patient safety who collaborative high 5s topics

From this to this!

The Productive Ward


  • Login